Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer — Stella

Home/Cancer/Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer

View on ClinicalTrials.gov

Recruiting

Back to Cancer trials

Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Sunstone Medical, PC, Rockville, Maryland

Key details

Phase

Safety & dosing

Sponsor

Sunstone Medical

Enrollment target

~56 participants

Started

October 2023

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.